Patent · US Active

Thienopyrimidines for pharmaceutical compositions

US8486953B2 · kind B2 · utility

1Cited by

4References

17Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Matthias Austen · Oebisfelde, DE
Phillip Black · Saffron Walden, GB
Wesley Blackaby · Cambridge, GB
John C. Danilewicz · Canterbury, GB
Ian Linney · London, GB
Kay Schreiter · Göttingen, DE
Martin Schneider · Remchingen, DE

Key dates

Filing date	Aug 24, 2009
Grant date	Jul 16, 2013
Priority date	—
Expiry date	Oct 18, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.